carbonthatcarbonthat
← Every company

Hims & Hers Health Inc Insider Trading

Every director, officer and 10% holder of Hims & Hers Health Inc has to report each trade in its stock within two business days of making it. This is those filings.

HIMS on carbonthat →
Insiders filing
15
91 reported lines
Open-market buys
0
Open-market sales
13
$6.1M
Net
$6.1M
sold more

Purchases and sales

Open-market trades only — the lines where someone chose to buy or sell at the going price.

InsiderActionValue
Oluyemi OkupeChief Financial Officer2026-09-2229.3K shat $29.95
Sale10b5-1 plan
$876.8K
Oluyemi OkupeChief Financial Officer2026-09-1712.3K shat $28.82
Sale10b5-1 plan
$354.9K
Soleil BoughtonChief Legal Officer2026-09-166.2K shat $27.86
Sale10b5-1 plan
$173.7K
Mohamed ElshenawyCTO2026-09-158K shat $28.39
Sale10b5-1 plan
$225.8K
Michael ChiChief Operating Officer2026-09-1514K shat $28.39
Sale10b5-1 plan
$398.2K
Soleil BoughtonChief Legal Officer2026-09-023.5K shat $28.33
Sale10b5-1 plan
$98K
Oluyemi OkupeChief Financial Officer2026-08-194.9K shat $29.99
Sale10b5-1 plan
$148.1K
Soleil BoughtonChief Legal Officer2026-08-1925.1K shat $27.55
Sale10b5-1 plan
$691.8K
Deborah M. AutorChief Policy Officer2026-08-1816.8K shat $27.85
Sale10b5-1 plan
$467.1K
Oluyemi OkupeChief Financial Officer2026-08-179.4K shat $27.89
Sale10b5-1 plan
$261.8K
Oluyemi OkupeChief Financial Officer2026-07-177.2K shat $31.99
Sale10b5-1 plan
$229.2K
Oluyemi OkupeChief Financial Officer2026-07-067.2K shat $36.49
Sale10b5-1 plan
$261.4K
Oluyemi OkupeChief Financial Officer2026-06-1855.4K shat $35.09
Sale10b5-1 plan
$1.9M

Source: SEC Form 4 filings, via EDGAR. A derivative line reports the shares underlying an option rather than stock outstanding, so it is marked and is not comparable with the rest. Value is shares times the reported price, and is blank where the filing priced the transaction at zero — a grant costs its recipient nothing. Insiders sell for reasons that have nothing to do with the company, which is why a sale is not read as a signal on its own.

More on HIMS

Company overviewEverything on HIMS in one place, with the price.SEC filingsWhat HIMS's 8-Ks say happened: results, departures, auditor changes.Planned salesSales HIMS insiders have filed notice of.Executive payWhat HIMS awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in HIMS.Funds holding itWhich funds and ETFs hold HIMS, and how big a bet.LobbyingWhat HIMS spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on HIMS's account, and who they worked for.

Follow Hims & Hers Health Inc (HIMS) by email

New trades in Hims & Hers Health Inc (HIMS) by members of Congress, insiders and funds, with the rest of the week's filings. One email a week, free.

Unsubscribe with one click from any email.

Related datasets

PeopleCEOs, investors, public officials and market commentators.SEC FilingsAuditor changes, restatements, departures and results, from 8-Ks.Insider BuyingCluster buys, and chief executives buying their own stock.The InsidersOne page per filer: every company they file against.